Maravai Lifesciences Holdings (MRVI) EBIAT: 2020-2025
Historic EBIAT for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$45.1 million.
- Maravai Lifesciences Holdings' EBIAT rose 73.87% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 33.91%. This contributed to the annual value of -$259.6 million for FY2024, which is 87.62% down from last year.
- According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' EBIAT is -$45.1 million, which was up 35.48% from -$69.8 million recorded in Q2 2025.
- In the past 5 years, Maravai Lifesciences Holdings' EBIAT ranged from a high of $156.7 million in Q2 2022 and a low of -$172.5 million during Q3 2024.
- Over the past 3 years, Maravai Lifesciences Holdings' median EBIAT value was -$45.1 million (recorded in 2025), while the average stood at -$51.4 million.
- As far as peak fluctuations go, Maravai Lifesciences Holdings' EBIAT surged by 9,227.12% in 2021, and later crashed by 1,582.49% in 2024.
- Over the past 5 years, Maravai Lifesciences Holdings' EBIAT (Quarterly) stood at $127.1 million in 2021, then crashed by 31.22% to $87.4 million in 2022, then crashed by 225.80% to -$110.0 million in 2023, then spiked by 58.11% to -$46.1 million in 2024, then skyrocketed by 73.87% to -$45.1 million in 2025.
- Its EBIAT was -$45.1 million in Q3 2025, compared to -$69.8 million in Q2 2025 and -$52.9 million in Q1 2025.